


Ask a doctor about a prescription for LINEZOLID AUROVITAS SPAIN 600 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Linezolid Aurovitas Spain 600 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.
Contents of the pack
Linezolid is an antibiotic of the oxazolidinone group that works by preventing the growth of certain bacteria (germs) that cause infections.
Antibiotics are used to treat bacterial infections and do not work for viral infections such as the flu or the common cold.
It is essential that you follow the instructions regarding dosage, administration interval, and treatment duration as indicated by your doctor.
Do not store or reuse this medication. If you have any leftover antibiotic after finishing treatment, return it to the pharmacy for proper disposal. Do not throw away medications down the drain or in the trash.
It is used for the treatment of pneumonia and certain skin or subcutaneous tissue infections. Your doctor will have decided if this medication is suitable for treating your infection.
Do not take Linezolid Aurovitas Spain
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take Linezolid Aurovitas Spain.
Linezolid may not be suitable for you if you answer yesto any of the following questions. In that case, inform your doctor, as he/she will need to monitor your general health and blood pressure before and during treatment or may decide that another treatment is better for you.
Ask your doctor if you are not sure if any of these categories apply to your case.
The use of certain medications, including antidepressants and opioids, along with linezolid may cause a serotonin syndrome, a potentially life-threatening disease (see "Other medications and Linezolid Aurovitas Spain").
Be especially careful with Linezolid Aurovitas Spain
Inform your doctor before taking this medication if:
Inform your doctor immediately if the following appear during treatment:
Other medications and Linezolid Aurovitas Spain
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
Occasionally, linezolid may interact with certain medications and produce adverse effects such as changes in blood pressure, body temperature, or heart rate.
Inform your doctor if you are taking or have taken in the last 2 weeksthe following medications, as you must nottake linezolid if you are still taking them or if you have taken them recently (see also section 2 above "Do not take Linezolid Aurovitas Spain"):
Also, inform your doctor if you are taking the following medications. Your doctor may decide to treat you with linezolid, but will need to assess your general condition and blood pressure before and during treatment. In other cases, your doctor may decide that another treatment is better for you.
Taking Linezolid Aurovitas Spain with food, drinks, and alcohol
Pregnancy, breastfeeding, and fertility
The effect of linezolid on pregnant women is unknown. Therefore, pregnant women should not take this medication unless advised by their doctor. If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Do not breastfeed while taking linezolid because this medication passes into breast milk and could affect your baby.
Driving and using machines
Linezolid may cause dizziness or vision problems. If this happens, do not drive or use machines. Remember that if you are not feeling well, your ability to drive or use machines may be affected.
Linezolid Aurovitas Spain contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medication.
Linezolid Aurovitas Spain contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per film-coated tablet; this is essentially "sodium-free".
Adults
Follow the instructions for administration of this medication contained in this leaflet or as indicated by your doctor, pharmacist, or nurse. In case of doubt, consult your doctor, pharmacist, or nurse again.
The recommended dose is one film-coated tablet (600 mg) twice a day (every 12 hours). You should swallow the film-coated tablet whole with a little water.
If you are on a dialysis program, you should take this medication after each session.
The normal treatment duration is 10-14 days, but it may be extended up to 28 days. The safety and efficacy of this medication have not been established for treatment periods longer than 28 days. Your doctor will decide the duration of your treatment.
While taking this medication, your doctor will perform periodic blood tests to monitor your blood count.
If you take this medication for more than 28 days, your doctor will need to monitor your vision.
Use in children and adolescents
Linezolid is not normally used in children or adolescents (under 18 years of age).
If you take more Linezolid Aurovitas Spain than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Linezolid Aurovitas Spain
Take the missed tablet as soon as you remember. Take the next tablet 12 hours later and continue taking the tablets every 12 hours. Do not take a double dose to make up for missed doses.
If you stop taking Linezolid Aurovitas Spain
It is essential that you only stop your treatment if your doctor indicates it.
If your initial symptoms return when you stop your treatment, inform your doctor or pharmacist immediately.
If you have any further questions about the use of this medication, ask your doctor, pharmacist, or nurse.
Like all medications, this medication can cause side effects, although not everybody gets them.
Inform your doctor, pharmacist, or nurse immediatelyif you notice any of the following side effects while taking linezolid:
The serious side effects of linezolid (whose frequency is between parentheses) are:
There have been reports of numbness, tingling, or blurred vision in patients who have taken linezolid for more than 28 days. If you experience vision difficulties, consult your doctor as soon as possible.
Other side effects include:
Frequent (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
The following side effects have also been reported (unknown: frequency cannot be estimated from available data):
Reporting of side effects
If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medications: www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date that appears on the box and on the blister after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE collection point in the pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
Composition of Linezolid Aurovitas Spain
The tablet core contains: poloxamer 407, sodium carboxymethyl starch (type A) (derived from potato starch), povidone K30, colloidal anhydrous silica, microcrystalline cellulose, lactose monohydrate, talc, and magnesium stearate.
The coating contains: hypromellose, polyethylene glycol 400 (macrogol), and titanium dioxide (E171).
Appearance of the Product and Package Contents
Linezolid Aurovitas Spain 600 mg film-coated tablets are white, oval, biconvex tablets.
Linezolid Aurovitas Spain tablets are available in PA/ALL/PVC-Aluminum or PVC/PE/PVDC-Aluminum blister strips with 10, 20, 30, 50, or 60 film-coated tablets.
Linezolid Aurovitas Spain tablets are also available in HDPE bottles with 10, 14, 20, 24, 30, 50, or 60 film-coated tablets, with a child-resistant screw cap.
Linezolid Aurovitas Spain tablets are also available in HDPE bottles with 100 film-coated tablets (for hospital use only).
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Manufacturer
Pharmathen International S.A.
Sapes Industrial Park Block 5
69300 Rodopi
Greece
Or
Pharmathen S.A.
6, Dervenakion str.
15351 Pallini, Attiki
Greece
This medicinal product is authorized in the Member States of the European Economic Area under the following names:
Austria: | Linezolid Pharmathen 600 mg Filmtabletten |
Germany: | Linezolid PUREN 600 mg Filmtabletten |
Spain: | Linezolid Aurovitas Spain 600 mg film-coated tablets EFG |
France: | LINEZOLIDE STRAGEN® 600 mg film-coated tablet |
Greece: | Lizedia |
Italy: | Linezolid Aurobindo Italia |
Portugal: | Linezolida Aurovitas |
Date of the Last Revision of this Leaflet: March 2025
Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es).
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LINEZOLID AUROVITAS SPAIN 600 mg FILM-COATED TABLETS – subject to medical assessment and local rules.